The Missing Bifurcation

Slides:



Advertisements
Similar presentations
Peripheral Arterial Disease :PAD. Introduction PAD caused by atherosclerotic occlusion of arteries to legs Prevalence 12% and increases to 20% if persons.
Advertisements

Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: Long-Term Angiographic and Clinical Outcome in >100 Patients Dimitris.
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Andrew Bunney MD, PGY-4 University of Minnesota
For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment Dr. Prasad Jetty Division of Vascular and Endovascular.
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Abdominal Aortic Aneurysm Case Study By Lisa Erwert.
Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.
Chronic arterial occlusive diseases.  Atherosclerosis( most common cause)  Aneurysms  Thrombangitis obliterans  Inflammatory arteritis Aetiology.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.
PERIPHERAL ARTERIAL DISEASE (PAD)
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
Achieving Acute Success and Durable Results with Complete Total Occlusion? Christopher J. Kwolek, MD FACS Harvard Medical School Division of Vascular and.
Peripheral Vascular Disease November 30, 2005 Basic Science Review St.-Luke’s Roosevelt.
Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:
Peripheral Vascular Disease
Material and Methods Patient Population. – From July 2005 through December 2008, 130 patients (130 procedures, 154 limbs, 185 lesions) were treated using.
Interventional Treatment of obstructive aortoiliac disease Dr Afshin Ghofraniha Interventional Cardiologist.
Mesenteric Ischemia: A Minimally Invasive Approach
The Endocross Enabler-P: First in-Human Results
Subclavian, Innominate & Vertebral Artery Treatment
Intervention for Chronic Lower Extremity Venous Obstruction
Management of Aortic and Aortoiliac Stenoses and Occlusions
LIVE CASE PRESENTATION MOUNT SINAI CARDIAC CATH LAB
Direct access of the SFA: step by step
LIVE CASE PRESENTATION MOUNT SINAI CARDIAC CATH LAB
Complex Ostial Disease of the Aortic Arch Vessels
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Michael Siah, M.D. Medstar Georgetown University Hospital
Treating Infrapopliteal Disease Using a Primarily Retrograde Technique
Stent Graft for the Treatment of ISR:
Director: Center for Critical Limb Care Riverside Methodist Hospital
Bhalaghuru Chokkalingam Mani MD
Aorta Infrarenal Stenosis: BE, SE or Covered Stents? CRT 2012
History : Case June 18’ year old male patient with complaints of life style limiting claudication symptoms in right leg at rest (Rutherford Grade.
Crossing SFA-Popliteal Artery CTO’s
A.Z. Sint-Blasius, Dendermonde
LIVE CASE PRESENTATION MOUNT SINAI CARDIAC CATH LAB
SFA Access for TASC D lesions.
History : Case March 26, year old male patient with complaints of left calf pain (Typical Claudication) at rest and on exertion (Fontaine II/B).
The Role of Interventional Treatment for The Failing Grafts
Recanilization of Central Venous Total Occlusions
Percutaneous Reconstruction of the Aortoiliac Bifurcation
Arterial ischemia – acute and chronic.
Essesntials for CTO Recanalization
ALAA GABI, MD SUPERVISOR: MEHIAR EL-HAMDANI, MD
James P. Zidar, M.D., F.A.C.C., F.S.C.A.I
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
Prashant Kaul, MD, FSCAI Piedmont Heart Institute, Atlanta, GA
L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, F
Endovascular Treatment of Acute Descending Thoracic Aortic Dissections
Endovascular techniques for arch vessel reconstruction
VASCULAR SURGERY STATIONS
Crystal M. Kavanagh, MD, Michael J. Heidenreich, MD, Jeremy J
Division of Endovascular Interventions
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices 
Arne Gerhard Schwindt, MD, Giuseppe Panuccio, MD, Konstantinos P
Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients  Christopher D.
Jaafer Golzar, MD, FACC, FSCAI  Journal of Indian College of Cardiology 
Michael S. Conte, MD  Journal of Vascular Surgery 
Technical aspects of repair of juxtarenal abdominal aortic aneurysms using the Zenith fenestrated endovascular stent graft  Gustavo S. Oderich, MD, Mateus.
Flow control technique to prevent distal embolization during mechanical thrombectomy  Mathew Wooster, MD, Daniel Kloda, DO, Jacob Robison, MD, Joseph Hart,
Division of Endovascular Interventions
Alternative access techniques with thoracic endovascular aortic repair, open iliac conduit versus endoconduit technique  Guido H.W. van Bogerijen, MD,
Division of Endovascular Interventions
Nicolas Mouawad, MD, Chief and Medical Director, Vascular and Endovascular Surgery, McLaren Bay Region A Tale of two lesions.
Presentation transcript:

The Missing Bifurcation Sasanka Jayasuriya MD, FACC Faisal Hasan MD, FACC, FSCAI Yale University, New Haven, CT

Case Presentation 75 yo male was referred for peripheral angiography with critical limb ischemia and Rutherford Class V claudication due to a non healing ulcer of the right lower limb for 2 months. Past History : Prior lower extremity stent – details not available Myocardial infarction 15 years ago without angiography or non invasive evaluation, carotid end arterectomy, hypertension, dyslipidemia, 100 pack year smoking history , current smoker. Relevant Examination : Vitals : HR 82/min, BP 148/82mmHg, Sats 94% on RA Right lower extremity : Pallor, dependent rubor, hair loss, 1 cm ulcer in dorsal aspect of right great toe. No gangrene. Absent femoral, pop, DP, PT pulse Investigations : ECG – Anterior Q waves. CBC, Renal function, Coag panel : normal

Diagnostic angiography Complete occlusion of right common iliac artery at origin. Minimal left to right collaterals

Retrograde angiography through R/SFA sheath. Ultrasound guided access was obtained in the mid right SFA by micro puncture technique 6F sheath was placed in R/SFA Retrograde angiography through R/SFA sheath.

A Stabilizer XS wire was advanced through the micro sheath to the descending aorta. Concern was raised if the entry point to the distal aorta was not within true lumen. IVUS examination was performed and intraluminal position was confirmed prior to dilatation. CIA diameter was measured to be 10-12mm by IVUS exam with dense calcification. Balloon angioplasty was performed in the CIA and EIA with a Vascutrak 6.0 X 80mm balloon at 6 atms

Angiography revealing channel formation following angioplasty IVUS exam to confirm intra luminal position in CIA

Orbital atherectomy Due to heavy calcification atherectomy with a CSI orbital atherectomy device with a 1.5burr was used at 60 – 90,000 rpm. Atherectomy helped avoid stenting of CFA

Final result 2 Abbott Absolute Self expanding stents Placed CIA : 10 X 80 mm EIA : 10 X 60 mm Post dilation Rival 8.0 X 40 mm balloon at 8 atms. Angioplasty of SFA and CFA performed with Rival balloon Following revascularization symptoms improved from Rutherford Class 5 to Class 1 and ulcer healed in 2 weeks.

Mortality associated with chronic CLI Patients presenting with chronic CLI have a mortality 20% at 1 year and 60% at 5 years High risk population Norgren L et al. Journal of Vascular Surgery. Volume 45, Issue 1, Supplement , Pages S5-S67, January 2007

Operative mortality and morbidity Adverse events leading to increased mortality and morbidity occur in >30% of patient undergoing lower extremity revascularization for CLI 40% of patients with CLI suffer from clinically significant CAD Peri operative MI 6% MI is silent in up to 30% MI is fatal in 50% suffering infarction Flu HC et al. Morbidity and Mortality caused by cardiac events after revascularization for critical limb ischemia. Ann Vasc Surg. 2009 Sep-Oct;23(5):583-97 Mamode N, Scott RN, McLaughlin SC, McLellland A, Pollack JG. Perioperative myocardial infarction in peripheral vascular surgery. B M J 1996;312:1396-1397.

TASC II Recommendations Inter-Society Consensus for the Management of Peripheral Arterial Disease s Unilateral occlusion of CIA and EIA : TASC D lesion Recommendation for TASC D lesions: Surgery is recommended treatment of choice for TASC D lesions (level of evidence C) Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1–75.

Revisiting our patient 75 yo with chronic CLI and previous MI with anterior Q waves, current smoker with 100 pack year history and carotid disease. Options Endovascular treatment under conscious sedation Surgical revascularization with aorto femoral by-pass with potential risks of induction of anesthesia, intubation, aortic cross clamp, hypovolemia, pain, hypothermia, reversal of anesthesia, surgical incision, bleeding, anemia and transfusion

Time to re-visit TASC II? Our case illustrates the success of endovascular revascularization in a safe and effective manner in a Class D lesion with the use of Re - entry device Atherectomy IVUS guidance and Stent placement The procedure has low morbidity and mortality lower cost and reduced length of stay in comparison with open surgical revascularization.

Critical limb ischemia Multi disciplinary evaluation Is this the missing bifurcation? Critical limb ischemia Multi disciplinary evaluation Endovascular operators, Vascular surgeons, Anesthetist, Cardiologist, Podiatrist High op Risk Low op Risk Surgical or Endo Endo

With the availability of new devices for use is now the time to support more aggressive endovascular revascularization in patients at high risk of peri-procedure cardiac events following multi disciplinary evaluation?